Example: Heart Attack

Clinical Trials on Disorders of Gallbladder, Biliary Tract and Pancrease

Total 10000 results

NCT02692911

Completed

Chile Biliary Longitudinal Study

Gallbladder Cancer | Nutritional and Metabolic Diseases
NCT04705740

Completed

Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography

Pancreatic Diseases | Biliary Disease
NCT06192719

Recruiting

EULAT Eradicate GBC (EULAT)

Gallbladder Cancer | Gallstone Disease
NCT03581435

Unknown

A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients (EXOGBC001)

Gallbladder Carcinoma | Proteinosis
NCT06123117

Recruiting

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy (STALL)

Cholecystitis | Cholelithiasis | Gallbladder Cancer
NCT06901622

Enrolling by invitation

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
NCT06282575

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Biliary Tract Cancer
NCT00609726

Completed

Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography

Pancreatitis | Gallbladder Disease
NCT07195643

Completed

Predictive Factors of Drain Insertion After Laparoscopic Cholecystectomy: A Cohort Study

Cholecystitis
NCT04259580

Recruiting

Calgary Registry for Advanced and Therapeutic Endoscopy (CReATE)

Pancreatic Diseases | Biliary Disease
NCT06717464

Active, not recruiting

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Hilar Cholangiocarcinoma | Gallbladder Cancer | Distal Cholangiocarcinoma
NCT07481760

Not yet recruiting

Acute Cholecystitis Biliary Complications - ICG (ICG-ACBC)

Biliary Complications | Acute Cholecystitis
NCT00253617

Withdrawn

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Cholangiocarcinoma of the Gallbladder
NCT00478140

Terminated

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

Malignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile Duct
NCT07176962

Recruiting

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Hilar Cholangiocarcinoma | Gall Bladder Cancer | Extrahepatic Cholangiocarcinoma | ctDNA | Intrahepatic Cholangiocarcinoma (Icc) | Billiary Track Cancer
NCT07452848

Recruiting

Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy

Gallbladder Diseases | Cholelithiasis
NCT03579758

Withdrawn

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Stage II Gallbladder Cancer AJCC v8 | Stage IIA Gallbladder Cancer AJCC v8 | Stage IIB Gallbladder Cancer AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Stage I Gallbladder Cancer AJCC v8
NCT06134193

Not yet recruiting

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Carcinoma | Intrahepatic Cholangiocarcinoma | Gallbladder Cancer | Immunotherapy | Tislelizumab | Surufatinib | Angiogenesis Inhibitors | Antineoplastic Agents, Immunological
NCT03160157

Withdrawn

Comparing the Outcomes of Laparoscopic Cholecystectomy vs. Robotic Cholecystectomy (RCT)

Gallbladder Diseases
NCT02827097

Withdrawn

The Effect of Rectus Sheath Block on the Postoperative Analgesia in the Patients Undergoing Robotic Single Port Cholecystectomy

Gallbladder Diseases
NCT00660140

Completed

Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer

Cholangiocarcinoma | Gallbladder Cancer
NCT06963060

Enrolling by invitation

Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) (GALENT-BT)

Cholangiocarcinoma | Gallbladder Cancer
NCT00350753

Completed

Avastin and Tarceva for Upper Gastrointestinal Cancers

Cholangiocarcinoma | Gallbladder Cancer
NCT04203160

Terminated

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Biliary Tract Cancer
NCT01242605

Completed

ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer (ABC-04)

Cholangiocarcinoma | Biliary Tract Neoplasms | Gallbladder Neoplasms
NCT01829139

Unknown

Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones

Common Bile Duct Stones | Gallbladder in Situ | Choleretics | Biliary Complications
NCT00356889

Completed

Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors

Gastrointestinal Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Cholangiocarcinoma of the Gallbladder
NCT00904865

Unknown

Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy

Cholecystitis | Symptomatic Gallbladder Stones | Biliary Pancreatitis
NCT07614061

Recruiting

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Biliary Tract Neoplasms | Gallbladder Cancer | Cholangiocarcinoma, Perihilar | Cholangiocarcinoma, Extrahepatic | Cholangiocarcinoma, Intrahepatic
NCT05620498

Recruiting

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
NCT04637048

Enrolling by invitation

Observational Study on Patients With Hepatobiliary Tumors

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer
NCT06178848

Completed

EEG Parameters Between Remimazolam- and Propofol-based Anesthesia

Cholecystitis, Acute | Acalculous Cholecystitis | Gallbladder Neoplasms
NCT02185586

Completed

A Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic Cholecystectomy

Gallbladder Stone | Gallbladder Polyp
NCT06708390

Completed

Single-Incision Laparoscopic Cholecystectomy with Inflexible Laparoscopic Instruments and Laparoscopy: a Single-Center Experience

Benign Gallbladder Disease
NCT03510923

Completed

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy (FANCY)

Gallbladder Neoplasms | Cholecystectomy | Appendiceal Neoplasms | Appendix | Appendectomy | Gallbladder
NCT01267344

Completed

A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC (BTC)

Cholangiocarcinoma | Adenocarcinoma of Gallbladder
NCT01313377

Completed

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer
NCT01875549

Withdrawn

Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent

Hepatocellular Carcinoma | Cholangiocarcinoma | Gall Bladder Cancer | Obstruction of Biliary Tree | Malignant Lymphadenopathy
NCT01118897

Completed

Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers

Pancreatic Neoplasms Malignant | Malignant Neoplasm of Gall Bladder Non-resectable
NCT00409864

Completed

Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer

Gallbladder Cancer | Obstructive Jaundice
NCT07568080

Not yet recruiting

SnapChole: An International, Time-Bound Prospective Platform Study of Management Strategies and Outcomes in Acute Calculous Cholecystitis (SnapChole)

Cholecystitis, Acute
NCT07575360

Completed

PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis Patients (EPIC-GBD)

Cholecystitis, Acute
NCT06223061

Completed

Global Evaluation of Cholecystectomy Knowledge and Outcomes (GECKO)

Gallbladder Cancer | Gallstone | Bile Duct Injury
NCT02951169

Unknown

Exploration of Standard Surgical Indication in Gallbladder Benign Disease

Cholecystitis | Gallbladder Polyps | Gallbladder Stone
NCT07269158

Not yet recruiting

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Advanced Cancer | Biliary Tract Neoplasms | Immunotherapy
NCT06246448

Recruiting

Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP) (ROBOCOP)

Gall Bladder Cancer
NCT03326154

Recruiting

Post-Cholecystectomy Quality of Life

Gallstone
NCT06178445

Active, not recruiting

Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer (TRAP-BTC)

Biliary Tract Cancer | HER2 Gene Mutation | HER2
NCT05596370

Recruiting

Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer

Pancreatic Cancer | Cholangiocarcinoma | Gallbladder Cancer
NCT01413633

Completed

A Novel Technique For Gall Bladder Fundus Retraction In Single Incision Laparoscopic Cholecystectomy

Gallbladder Diseases

Clinical Trials on Disorders of Gallbladder, Biliary Tract and Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations